Lupin Ltd. (LUPIN)
NSE
Closed
Sep 9, 2026
Day's Range
2,090.0052 wk Range
1,900.00Overview - LUPIN - Lupin Ltd.
Key Statistics
Valuation
Enterprise Value
982.45B
P/E (Trailing)
‪18.09‬
P/E (Forward)
‪21.39‬
PEG Ratio
‪0.21‬
Price / Sales (TTM)
‪3.33‬
Price / Book
‪4.44‬
EV / EBITDA
‪11.36‬
Profitability
Gross Margin
‪74.57%‬
Profit Margin
‪18.45%‬
Operating Margin
‪25.35%‬
Return on Assets
‪13.90%‬
Return on Equity
‪23.68%‬
Ownership
Shares Outstanding
457.26M
Float
241.80M
Held by Insiders
‪47.02%‬
Held by Institutions
‪35.52%‬
Price stats
Beta
‪0.18‬
50-Day Avg
‪2,373.34‬
200-Day Avg
‪2,262.54‬
Dividends
Payout Ratio
‪9.94%‬
Frequency
Annual
Analyst Consensus
36 analysts
Average price target
‪₹ 2,513.22‬Market Cap - LUPIN - Lupin Ltd.
Peers - LUPIN - Lupin Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NSE.
- LUPINNSELupin Ltd.992.95BMarket Cap+12.96%52-week change18.10P/E (Trailing)‪18.45%‬Profit Margin
- DIVISLABNSEDivi's Laboratories Ltd.2.45TMarket Cap+34.05%52-week change95.31P/E (Trailing)‪26.04%‬Profit Margin
- CIPLANSECipla Ltd.1.14TMarket Cap-11.50%52-week change34.09P/E (Trailing)‪12.00%‬Profit Margin
- LAURUSLABSNSELaurus Labs Ltd.1.04TMarket Cap+55.80%52-week change95.68P/E (Trailing)‪15.04%‬Profit Margin
- DRREDDYNSEDr. Reddy's Laboratories Ltd.981.26BMarket Cap-8.65%52-week change29.70P/E (Trailing)‪9.99%‬Profit Margin
- MANKINDNSEMankind Pharma Ltd.953.72BMarket Cap-15.82%52-week change46.78P/E (Trailing)‪13.85%‬Profit Margin
- AUROPHARMANSEAurobindo Pharma Ltd.951.15BMarket Cap+37.08%52-week change25.98P/E (Trailing)‪10.62%‬Profit Margin
Profile Summary - LUPIN - Lupin Ltd.
About
Lupin Ltd. is a multinational pharmaceutical company based in India. It is primarily involved in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company's product portfolio includes generic and branded formulations, active pharmaceutical ingredients (APIs), and specialties…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
